{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:09:33Z","timestamp":1793372973480,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the key research and development project of Zhejiang Province","award":["No.2022C03050"],"award-info":[{"award-number":["No.2022C03050"]}]},{"name":"the Key Science and Technology Project of Jinhua City, Zhejiang Province","award":["No.2020-1-025"],"award-info":[{"award-number":["No.2020-1-025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11033-022-08102-9","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T19:42:20Z","timestamp":1669923740000},"page":"1321-1331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma"],"prefix":"10.1007","volume":"50","author":[{"given":"Qiaoqiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-8687","authenticated-orcid":false,"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"8102_CR1","doi-asserted-by":"publisher","first-page":"9267","DOI":"10.3390\/ijms21239267","volume":"21","author":"M Dal Monte","year":"2020","unstructured":"Dal Monte M, Cammalleri M, Amato R, Pezzino S, Corsaro R, Bagnoli P, Rusciano D (2020) A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int J Mol Sci 21:9267","journal-title":"Int J Mol Sci"},{"key":"8102_CR2","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.4103\/1673-5374.274325","volume":"15","author":"J Fern\u00e1ndez-Albarral","year":"2020","unstructured":"Fern\u00e1ndez-Albarral J, de Hoz R, Ram\u00edrez A, L\u00f3pez-Cuenca I, Salobrar-Garc\u00eda E, Pinazo-Dur\u00e1n M, Ram\u00edrez J, Salazar J (2020) Beneficial effects of saffron (Crocus sativus L.) in ocular pathologies, particularly neurodegenerative retinal diseases. Neural Regen Res 15:1408\u20131416","journal-title":"Neural Regen Res"},{"key":"8102_CR3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y Tham","year":"2014","unstructured":"Tham Y, Li X, Wong TY, Quigley HA, Aung T, Cheng C (2014) Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophthalmology 121:2081\u20132090","journal-title":"Ophthalmology"},{"key":"8102_CR4","doi-asserted-by":"publisher","first-page":"130498","DOI":"10.1016\/j.cej.2021.130498","volume":"425","author":"J Wang","year":"2021","unstructured":"Wang J, Li B, Huang D, Norat P, Grannonico M, Cooper RC, Gui Q, Chow N, Liu W, Yang H (2021) Nano-in-Nano dendrimer gel particles for efficient topical delivery of antiglaucoma drugs into the eye. Chem Eng J 425:130498","journal-title":"Chem Eng J"},{"key":"8102_CR5","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1039\/D0BM01013H","volume":"8","author":"MJ Rodrigo","year":"2020","unstructured":"Rodrigo MJ, Cardiel MJ, Fraile JM, Mendez-Martinez S, Martinez-Rincon T, Subias M, Polo V, Ruberte J, Ramirez T, Vispe E, Luna C, Mayoral JA, Garcia-Martin E (2020) Brimonidine-LAPONITE (R) intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model. Biomater Sci-Uk 8:6246\u20136626","journal-title":"Biomater Sci-Uk"},{"key":"8102_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41419-020-03337-5","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen S, Wang J, Liu Y, Chen Y, Wen T, Fang X, Vidal-Sanz M, Jonas JB, Zhang X (2021) MicroRNA-93\/STAT3 signalling pathway mediates retinal microglial activation and protects retinal ganglion cells in an acute ocular hypertension model. Cell Death Dis 12:41","journal-title":"Cell Death Dis"},{"key":"8102_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/1673-5374.245465","volume":"14","author":"A Adornetto","year":"2019","unstructured":"Adornetto A, Russo R, Parisi V (2019) Neuroinflammation as a target for glaucoma therapy. Neural Regen Res 14:391\u2013394","journal-title":"Neural Regen Res"},{"key":"8102_CR8","doi-asserted-by":"crossref","unstructured":"Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM (2021) Inflammation in Glaucoma: From the back to the front of the eye, and beyond.Prog Retin Eye Res83","DOI":"10.1016\/j.preteyeres.2020.100916"},{"key":"8102_CR9","doi-asserted-by":"crossref","unstructured":"Wilson GN, Inman DM, Dengler-Crish CM, Smith MA, Crish SD (2015) Early pro-inflammatory cytokine elevations in the DBA\/2J mouse model of glaucoma.J Neuroinflamm12","DOI":"10.1186\/s12974-015-0399-0"},{"key":"8102_CR10","doi-asserted-by":"publisher","first-page":"E285","DOI":"10.1097\/IJG.0000000000001844","volume":"30","author":"T Chakravarti","year":"2021","unstructured":"Chakravarti T, Moghadam M, Proudfoot JA, Weinreb RN, Bowd C, Zangwill LM (2021) Agreement Between 10 \u2013 2 and 24-2\u00a0C Visual Field Test Protocols for Detecting Glaucomatous Central Visual Field Defects. J Glaucoma 30:E285\u2013E291","journal-title":"J Glaucoma"},{"key":"8102_CR11","doi-asserted-by":"crossref","unstructured":"Lin S, Li Q, Jiang S, Xu Z, Jiang Y, Liu L, Jiang J, Tong Y, Wang P (2021) Crocetin ameliorates chronic restraint stress-induced depression-like behaviors in mice by regulating MEK\/ERK pathways and gut microbiota.J Ethnopharmacol268","DOI":"10.1016\/j.jep.2020.113608"},{"key":"8102_CR12","doi-asserted-by":"crossref","unstructured":"Bolhassani A (2018) Bioactive Components of Saffron and Their Pharmacological Properties, Vol.\u00a058, pp.\u00a0289\u2013311","DOI":"10.1016\/B978-0-444-64056-7.00010-6"},{"key":"8102_CR13","doi-asserted-by":"publisher","first-page":"114873","DOI":"10.1016\/j.jep.2021.114873","volume":"285","author":"Z Xu","year":"2022","unstructured":"Xu Z, Lin S, Tong Z, Chen S, Cao Y, Li Q, Jiang Y, Cai W, Tong Y, Zahra BS, Wang P (2022) Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. J Ethnopharmacol 285:114873","journal-title":"J Ethnopharmacol"},{"key":"8102_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.18433\/J3MW3N","volume":"18","author":"JR Bend","year":"2015","unstructured":"Bend JR, Xia XY, Chen D, Awaysheh A, Lo A, Rieder MJ, Rylett RJ (2015) Attenuation of Oxidative Stress in HEK 293 Cells by the TCM Constituents Schisanhenol, Baicalein, Resveratrol or Crocetin and Two Defined Mixtures. J Pharm Pharm Sci 18:661\u2013682","journal-title":"J Pharm Pharm Sci"},{"key":"8102_CR15","doi-asserted-by":"crossref","unstructured":"Wen Y, He Z, Hou D, Qin S (2021) Crocetin Exerts Its Anti-inflammatory Property in LPS-Induced RAW264.7 Cells Potentially via Modulation on the Crosstalk between MEK1\/JNK\/NF-\u03baB\/iNOS Pathway and Nrf2\/HO-1 Pathway. Oxid Med Cell Longev 2021: 1\u201318","DOI":"10.1155\/2021\/6631929"},{"key":"8102_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1017\/S0952523814000108","volume":"31","author":"S BISTI","year":"2014","unstructured":"BISTI S, MACCARONE R, FALSINI B (2014) Saffron and retina: Neuroprotection and pharmacokinetics. Visual Neurosci 31:355\u2013361","journal-title":"Visual Neurosci"},{"key":"8102_CR17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.biopha.2018.10.193","volume":"109","author":"H Wang","year":"2019","unstructured":"Wang H, Ma J, Shang Q, An J, Chen H, Wang C (2019) Safety, pharmacokinetics, and prevention effect of intraocular crocetin in proliferative vitreoretinopathy. Biomed Pharmacother 109:1211\u20131220","journal-title":"Biomed Pharmacother"},{"key":"8102_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejphar.2010.09.081","volume":"650","author":"M Yamauchi","year":"2011","unstructured":"Yamauchi M, Tsuruma K, Imai S, Nakanishi T, Umigai N, Shimazawa M, Hara H (2011) Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. Eur J Pharmacol 650:110\u2013119","journal-title":"Eur J Pharmacol"},{"key":"8102_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2013.02.007","volume":"703","author":"F Ishizuka","year":"2013","unstructured":"Ishizuka F, Shimazawa M, Umigai N, Ogishima H, Nakamura S, Tsuruma K, Hara H (2013) Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice. Eur J Pharmacol 703:1\u201310","journal-title":"Eur J Pharmacol"},{"key":"8102_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejphar.2012.06.035","volume":"690","author":"Y Ohno","year":"2012","unstructured":"Ohno Y, Nakanishi T, Umigai N, Tsuruma K, Shimazawa M, Hara H (2012) Oral administration of crocetin prevents inner retinal damage induced by N-methyl-d-aspartate in mice. Eur J Pharmacol 690:84\u201389","journal-title":"Eur J Pharmacol"},{"key":"8102_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1442-9071.2012.02883.x","volume":"41","author":"H Kim","year":"2013","unstructured":"Kim H, Park J, Park S (2013) Experimental chronic ocular hypertension by anterior chamber injection of 0.3% carbomer solution in the rat. Clin Exp Ophthalmol 41:404\u2013412","journal-title":"Clin Exp Ophthalmol"},{"key":"8102_CR22","doi-asserted-by":"crossref","unstructured":"Qiu C, Yao J, Zhang X, Zhang R, Sun X, Qian S (2020) The Dynamic Scleral Extracellular Matrix Alterations in Chronic Ocular Hypertension Model of Rats. Front Physiol 11.","DOI":"10.3389\/fphys.2020.00682"},{"key":"8102_CR23","doi-asserted-by":"crossref","unstructured":"Shanmugham V, Subban R (2021) Extraction of capsanthin fromCapsicum annum L fruits and its effect on carbomer-induced intraocular pressure in Albino Wistar rats.J Food Biochem45","DOI":"10.1111\/jfbc.13776"},{"key":"8102_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1021\/acsmedchemlett.7b00264","volume":"8","author":"M Blangetti","year":"2017","unstructured":"Blangetti M, Rolando B, Marini E, Chegaev K, Guglielmo S, Lazzarato L, Lucarini L, Masini E, Fruttero R (2017) gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension. Acs Med Chem Lett 8:1054\u20131059","journal-title":"Acs Med Chem Lett"},{"key":"8102_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/ijms20040981","volume":"20","author":"C Lanzi","year":"2019","unstructured":"Lanzi C, Lucarini L, Durante M, Sgambellone S, Pini A, Catarinicchia S, \u0141a\u017cewska D, Kie\u0107-Kononowicz K, Stark H, Masini E (2019) Role of Histamine H3 Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma. Int J Mol Sci 20:981","journal-title":"Int J Mol Sci"},{"key":"8102_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000508631","volume":"64","author":"KN Sorkou","year":"2021","unstructured":"Sorkou KN, Manthou ME, Meditskou S, Tsinopoulos IT, Ziakas N, Kouzi-Koliakou K (2021) Lens Epithelial Surface Disorders in Exfoliation Syndrome: A Scanning and Transmission Electron Microscopy Study. Ophthalmic Res 64:216\u2013223","journal-title":"Ophthalmic Res"},{"key":"8102_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12974-021-02366-x","volume":"18","author":"X Hu","year":"2021","unstructured":"Hu X, Zhao GL, Xu MX, Zhou H, Li F, Miao Y, Lei B, Yang XL, Wang Z (2021) Interplay between Muller cells and microglia aggravates retinal inflammatory response in experimental glaucoma. J Neuroinflammation 18:303","journal-title":"J Neuroinflammation"},{"key":"8102_CR28","doi-asserted-by":"crossref","unstructured":"Yaman D, Takmaz T, Y\u00fcksel N, Din\u00e7er SA, \u015eahin F (2020) 0. Evaluation of silent information regulator T (SIRT) 1 and Forkhead Box O (FOXO) transcription factor 1 and 3a genes in glaucoma. Mol Biol Rep 47: 9337\u20139344","DOI":"10.1007\/s11033-020-05994-3"},{"key":"8102_CR29","doi-asserted-by":"crossref","unstructured":"Dias MS, Luo X, Ribas VT, Petrs-Silva H, Koch JC (2022) The Role of Axonal Transport in Glaucoma.Int J Mol Sci23","DOI":"10.3390\/ijms23073935"},{"key":"8102_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41419-021-04445-6","volume":"12","author":"M Ye","year":"2021","unstructured":"Ye M, Huang J, Mou Q, Luo J, Hu Y, Lou X, Yao K, Zhao B, Duan Q, Li X, Zhang H, Zhao Y (2021) CD82 protects against glaucomatous axonal transport deficits via mTORC1 activation in mice. Cell Death Dis 12:1149","journal-title":"Cell Death Dis"},{"key":"8102_CR31","doi-asserted-by":"publisher","first-page":"108797","DOI":"10.1016\/j.exer.2021.108797","volume":"212","author":"S Ma","year":"2021","unstructured":"Ma S, Zhang K, Zhu Y, Cao X, Wang L (2021) Effect of papaverine on axonal outgrowth of primary retinal ganglion cells of Sprague Dawley rats. Exp Eye Res 212:108797","journal-title":"Exp Eye Res"},{"key":"8102_CR32","doi-asserted-by":"publisher","first-page":"e107446","DOI":"10.1371\/journal.pone.0107446","volume":"9","author":"H Yun","year":"2014","unstructured":"Yun H, Lathrop KL, Yang E, Sun M, Kagemann L, Fu V, Stolz DB, Schuman JS, Du Y (2014) A laser-induced mouse model with long-term intraocular pressure elevation. PLoS ONE 9:e107446","journal-title":"PLoS ONE"},{"key":"8102_CR33","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1167\/iovs.17-21761","volume":"58","author":"JA Schaub","year":"2017","unstructured":"Schaub JA, Kimball EC, Steinhart MR, Nguyen C, Pease ME, Oglesby EN, Jefferys JL, Quigley HA (2017) Regional Retinal Ganglion Cell Axon Loss in a Murine Glaucoma Model. Invest Ophth Vis Sci 58:2765\u20132773","journal-title":"Invest Ophth Vis Sci"},{"key":"8102_CR34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamaophthalmol.2021.2617","volume":"139","author":"JY E","year":"2021","unstructured":"E JY, Mihailovic A, Garzon C, Schrack JA, Li T, West SK, Gitlin LN, Friedman DS, Ramulu PY (2021) Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma. Jama Ophthalmol 139:1053\u20131060","journal-title":"Jama Ophthalmol"},{"key":"8102_CR35","doi-asserted-by":"publisher","first-page":"9366","DOI":"10.1038\/s41598-022-12036-4","volume":"12","author":"RL Bartlett","year":"2022","unstructured":"Bartlett RL, Frost BE, Mortlock KE, Fergusson JR, White N, Morgan JE, North RV, Albon J (2022) Quantifying biomarkers of axonal degeneration in early glaucoma to find the disc at risk. Sci Rep 12:9366","journal-title":"Sci Rep"},{"key":"8102_CR36","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1007\/s10792-021-01959-y","volume":"41","author":"YW Cha","year":"2021","unstructured":"Cha YW, Kim ST (2021) Serum and aqueous humor levels of brain-derived neurotrophic factor in patients with primary open-angle glaucoma and normal-tension glaucoma. Int Ophthalmol 41:3869\u20133875","journal-title":"Int Ophthalmol"},{"key":"8102_CR37","doi-asserted-by":"publisher","first-page":"875662","DOI":"10.3389\/fphar.2022.875662","volume":"13","author":"L Lambuk","year":"2022","unstructured":"Lambuk L, Mohd LM, Ahmad S, Iezhitsa I, Agarwal R, Uskokovic V, Mohamud R (2022) Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Front Pharmacol 13:875662","journal-title":"Front Pharmacol"},{"key":"8102_CR38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.4103\/1673-5374.346546","volume":"18","author":"M Lazaldin","year":"2023","unstructured":"Lazaldin M, Iezhitsa I, Agarwal R, Agarwal P, Ismail NM (2023) Neuroprotective effects of exogenous brain-derived neurotrophic factor on amyloid-beta 1-40-induced retinal degeneration. Neural Regen Res 18:382\u2013388","journal-title":"Neural Regen Res"},{"key":"8102_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","volume":"31","author":"M Almasieh","year":"2012","unstructured":"Almasieh M, Wilson AM, Morquette B, Vargas C, Di Polo A (2012) The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 31:152\u2013181","journal-title":"Prog Retin Eye Res"},{"key":"8102_CR40","doi-asserted-by":"publisher","first-page":"108225","DOI":"10.1016\/j.exer.2020.108225","volume":"200","author":"AG Hvozda Arana","year":"2020","unstructured":"Hvozda Arana AG, Vitar L, Reides RM, Lerner CG, Ferreira SM (2020) Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model. Exp Eye Res 200:108225","journal-title":"Exp Eye Res"},{"key":"8102_CR41","doi-asserted-by":"crossref","unstructured":"Krishnan A, Kocab AJ, Zacks DN, Marshak-Rothstein A, Gregory-Ksander M (2019) A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.J Neuroinflamm16","DOI":"10.1186\/s12974-019-1576-3"},{"key":"8102_CR42","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.preteyeres.2021.100998","volume":"87","author":"G Tezel","year":"2022","unstructured":"Tezel G (2022) Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets. Prog Retin Eye Res 87:100998","journal-title":"Prog Retin Eye Res"},{"key":"8102_CR43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1515\/tnsci-2018-0020","volume":"9","author":"Q Yang","year":"2018","unstructured":"Yang Q, Li Y, Luo L (2018) Effect of myricetin on primary open-angle glaucoma. Transl Neurosci 9:132\u2013141","journal-title":"Transl Neurosci"},{"key":"8102_CR44","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.survophthal.2021.12.001","volume":"67","author":"S Chaudhry","year":"2022","unstructured":"Chaudhry S, Dunn H, Carnt N, White A (2022) Nutritional supplementation in the prevention and treatment of glaucoma. Surv Ophthalmol 67:1081\u20131098","journal-title":"Surv Ophthalmol"},{"key":"8102_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s13318-017-0449-3","volume":"43","author":"A Hosseini","year":"2018","unstructured":"Hosseini A, Razavi BM, Hosseinzadeh H (2018) Pharmacokinetic Properties of Saffron and its Active Components. Eur J Drug Metab Ph 43:383\u2013390","journal-title":"Eur J Drug Metab Ph"},{"key":"8102_CR46","doi-asserted-by":"publisher","first-page":"106713","DOI":"10.1016\/j.intimp.2020.106713","volume":"86","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wang Z, Fu X, Lin Z, Yu K (2020) Geraniol-mediated osteoarthritis improvement by down-regulating PI3K\/Akt\/NF-\u03baB and MAPK signals: In vivo and in vitro studies. Int Immunopharmacol 86:106713","journal-title":"Int Immunopharmacol"},{"key":"8102_CR47","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/med.21842","volume":"41","author":"T Efferth","year":"2021","unstructured":"Efferth T, Oesch F (2021) The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases. Med Res Rev 41:3023\u20133061","journal-title":"Med Res Rev"},{"key":"8102_CR48","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1021\/acsami.0c18626","volume":"13","author":"S Schnichels","year":"2021","unstructured":"Schnichels S, Hurst J, de Vries JW, Ullah S, Fr\u00f6\u00dfl K, Gruszka A, L\u00f6scher M, Bartz-Schmidt K, Spitzer MS, Herrmann A (2021) Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles. Acs Appl Mater Inter 13:9445\u20139456","journal-title":"Acs Appl Mater Inter"},{"key":"8102_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.clinthera.2019.12.008","volume":"42","author":"R Belfort","year":"2020","unstructured":"Belfort R, Paula JS, Lopes Silva MJ, Della Paolera M, Kim T, Chen MY, Goodkin ML (2020) Fixed-combination Bimatoprost\/Brimonidine\/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil*. Clin Ther 42:263\u2013275","journal-title":"Clin Ther"},{"key":"8102_CR50","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.exer.2008.02.008","volume":"86","author":"M Hern\u00e1ndez","year":"2008","unstructured":"Hern\u00e1ndez M, Urcola JH, Vecino E (2008) Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Exp Eye Res 86:798\u2013806","journal-title":"Exp Eye Res"},{"key":"8102_CR51","doi-asserted-by":"crossref","unstructured":"Jung K, Kim H, Kee Park C (eds) (2015) \u03b12-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model. Eur J Pharmacol 765: 274\u2013283","DOI":"10.1016\/j.ejphar.2015.08.035"},{"key":"8102_CR52","doi-asserted-by":"publisher","first-page":"e2514","DOI":"10.1038\/cddis.2016.397","volume":"7","author":"S Nizari","year":"2016","unstructured":"Nizari S, Guo L, Davis BM, Normando EM, Galvao J, Turner LA, Bizrah M, Dehabadi M, Tian K, Cordeiro MF (2016) Non-amyloidogenic effects of \u03b12 adrenergic agonists: implications for brimonidine-mediated neuroprotection. Cell Death Dis 7:e2514\u2013e2514","journal-title":"Cell Death Dis"},{"key":"8102_CR53","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neulet.2006.03.066","volume":"402","author":"A Lymperopoulos","year":"2006","unstructured":"Lymperopoulos A, Karkoulias G, Koch WJ, Flordellis CS (2006) \u03b12-Adrenergic receptor subtype-specific activation of NF-\u03baB in PC12 cells. Neurosci Lett 402:210\u2013215","journal-title":"Neurosci Lett"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08102-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-08102-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08102-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T13:54:31Z","timestamp":1675346071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-08102-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["8102"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-08102-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of competing interest"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed. All animal studies were carried out as per the Guidelines for the Care and Use of Laboratory Animals at the Zhejiang University of Technology in Hangzhou, China, provided vide ethical code No. 20200810104.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}